Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics in Schizophrenic Patients

NCT04240496 is registered in ClinicalTrials.gov with University of Monastir as lead sponsor.

NCT NCT04240496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04240496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics in Schizophrenic Patients
Lead sponsor
University of Monastir
Phase
Not applicable
Overall status
Completed
Start date
October 17, 2019
Completion date
December 14, 2019
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clozapine, cyp1a2 polymorphism, cyp2c19 polymorphism, schizophrenia